Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Equity / Common Shares, no par value per share
-
Shares outstanding
-
47,601,550
-
Total 13F shares
-
22,521,153
-
Share change
-
-8,188,589
-
Total reported value
-
$4,301,583
-
Put/Call ratio
-
84%
-
Price per share
-
$0.19
-
Number of holders
-
32
-
Value change
-
-$19,774,211
-
Number of buys
-
16
-
Number of sells
-
19
Institutional Holders of ESSA Pharma Inc. - Common Shares, no par value per share (EPIX) as of Q3 2025
As of 30 Sep 2025,
ESSA Pharma Inc. - Common Shares, no par value per share (EPIX) was held by
32 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
22,521,153 shares.
The largest 10 holders included
BVF INC/IL, Soleus Capital Management, L.P., MORGAN STANLEY, Pfizer Inc, BANK OF AMERICA CORP /DE/, LMR Partners LLP, Shay Capital LLC, TWO SIGMA INVESTMENTS, LP, TWO SIGMA ADVISERS, LP, and CITADEL ADVISORS LLC.
This page lists
32
institutional shareholders reporting positions in this security
for the Q3 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.